E-viri
-
Biotech Week, 06/2005Newsletter
Robert Gasparini, the company's president, stated, "I am very pleased with the progress we have made in marketing our new fluorescence insitu hybridization (FISH) and flow cytometry testing platforms, both of which are complimentary to our core cytogenetics business. Our customers have seen the immediate value in ordering these additional laboratory services, and in just the first few months our clients have adapted these technologies into their ordering practices."
